REG - ConvaTec Group PLC - Scrip Dividend - Total Issued Shares

ConvaTecAnnouncement

28/09/2021 15:15

RNS Number : 2612N
  
ConvaTec Group PLC
  
28 September 2021
  
 

ConvaTec Group Plc
 
Scrip Dividend - Total Issued Shares
 
 
Reading, United Kingdom (28 September 2021)
The Board of Directors of ConvaTec Group Plc ("ConvaTec" or "the Company") declared an interim dividend in respect of 2021 of 1.717 cents per share ("Interim Dividend"). The Interim Dividend is to be paid on 14 October 2021 to shareholders on the share register at 3 September 2021 ("Record Date"). The dividend is payable in cash in sterling to holders of ordinary shares. On 30 July 2021, the Company announced that a scrip dividend would be made available for the Interim Dividend, allowing shareholders to elect to receive their dividend in the form of new ordinary shares. The calculation price for the scrip dividend was announced on 9 September 2021.
It is confirmed that 750,265 new ordinary shares of 10 pence each will be allotted and issued on 14 October 2021 by the Company to those shareholders who elected to receive the scrip dividend alternative. The shares will rank pari passu with the existing issued ordinary shares of the Company. Application will be made to the Financial Conduct Authority for the shares to be admitted to the Official List and to the London Stock Exchange for the shares to be admitted to trading.
Following the issue of shares under the scrip dividend scheme in respect of the Interim Dividend, the Company's issued share capital will be 2,014,572,935 ordinary shares of 10 pence each.
Dealings in the shares issued under the scrip dividend scheme are expected to commence on 14 October 2021.
 
Details of the scrip dividend scheme are available at www.convatecgroup.com/investors.
TIMETABLE
Key dates in respect of the scrip dividend scheme for the Interim Dividend are:




Ex-dividend Date


   2 September 2021




Record Date


3 September 2021




Scrip calculation price determined


    2-8 September 2021 (inclusive)




Scrip calculation price available and announced


                9 September 2021




Mandate delivery deadline for Shares held in uncertificated form 


  3.00 p.m. on 21 September 2021 




Mandate delivery deadline for Shares held in certificated form


5.00 p.m. on 21 September 2021 




  Announcement of the total amount of new shares to be issued


                       28 September 2021




  Dividend payment date


                            14 October 2021




  Dispatch of statement in accordance with section 7 of Scheme


                            14 October 2021 




Rules and share certificates, CREST accounts credited/updated, 
and first day of dealings in New Shares
                                                                                                           
 
 
 
Enquiries
Analysts and Investors
Kate Postans, VP, Investor Relations &                                                  +44 (0)782 644 7807
Corporate Communications                                                        
ir@convatec.com
 
Media
Buchanan: Charles Ryland / Chris Lane                                                +44 (0)207 466 5000                                                                                                           
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
 
 
 
 
# # #
END
 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DIVFLFSVAIITFIL